Adamis Pharmaceuticals (NASDAQ:ADMP) reported quarterly losses of $(0.06) per share which missed the analyst consensus estimate of $(0.03) by 100 percent. This is unchanged from the same period last year.
Dada Nexus Q2 Sales $345.58M Beat $329.72M Estimate
Dada Nexus (NASDAQ:DADA) reported quarterly sales of $345.58 million which beat the analyst consensus estimate of $329.72 million by 4.81 percent. This is a 51.39 percent increase over sales of $228.27 million the same
